Researcher, Department of Clinical Neuroscience and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
I am a researcher at the Department of Clinical Neuroscience and the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. I obtained my PhD at Karolinska Institutet and completed postdoctoral fellowships at the University of Oxford and at Karolinska Institutet.
My research is mostly focused on pharmacoepidemiology. That is, I study the risks and benefits of common medications with a specific interest in psychiatric and behavioural outcomes such as depression, anxiety, suicide, overdoses, accidents, violence and other crimes. For this, I use Swedish pharmacy, healthcare, sociodemographic, crime and death registers, and I study nationwide cohorts of people who take different medications. I have previously published studies on the psychiatric and behavioural outcomes of antidepressants, nicotine replacement therapy, antiepileptic drugs, cholesterol-lowering medications, and medications for treating substance use disorders.
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
Labour can afford to be far more ambitious with its economic policies – voters are on board
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects